Mizuho analyst Ann Hynes raised the firm’s price target on Molina Healthcare (MOH) to $220 from $200 and keeps an Outperform rating on the shares. The firm updated targets in the healthcare facilities and managed care group as part of a Q4 preview. Mizuho’s physician survey indicated healthcare utilization growth trends decelerated sequentially despite easier year-over-year comps, which could indicate trend is peaking, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Trump Trade: Trump says Venezuela to give U.S. up to 50M barrels of oil
- Molina Healthcare price target raised to $208 from $165 at Wells Fargo
- Trump says he will meet with 14 health insurers in a few days
- Molina Healthcare price target raised to $224 from $182 at Bernstein
- Molina Healthcare price target lowered to $175 from $190 at Truist